ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

CCI Gets Qualified Approval To Continue

January 18, 1980

Review Of DCCR Programs Uncovers Problems, Assigns Scores To Each

June 30, 1978

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Murray Copeland Display Dedicated

March 18, 1983